Fioriti L, Wijesekara N, Argyrousi EK, Matsuzaki S, et al. Genetic and pharmacologic enhancement of SUMO2 conjugation prevents and reverses cognitive impairment and synaptotoxicity in a preclinical model of Alzheimer's disease. Alzheimers Dement 2025;21:e70030.
PMID: 40047257